CMPX vs NVDA · $367.4M cap vs P/E 58, rev $96.22B
Compass Therapeutics Inc. (CMPX) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
CMPX does not have a complete income-statement cache yet.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
CMPX currently screens at market cap $367.4M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the CMPX and NVDA stock pages for the full models.
Not investment advice.